Demographic and Asthma-Related Characteristics of Asthmatics Using Pressurized Metered Dose Inhalers and Dry Powder Inhalers

Basit Öğe Kaydı
dc.authoridAksu, Kurtulus/0000-0001-6195-1158
dc.contributor.authorAksu, Kurtulus
dc.contributor.authorSolak, Gurgun Tugce Vural
dc.contributor.authorMutlu, Levent Cem
dc.contributor.authorMutlu, Pinar
dc.contributor.authorSahin, Gorkem Vayisoglu
dc.contributor.authorTure, Ezgi Erdem
dc.contributor.authorYormaz, Burcu
dc.date.accessioned2024-10-29T17:58:37Z
dc.date.available2024-10-29T17:58:37Z
dc.date.issued2024
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.description.abstractBackground: Asthma controller medications can be delivered via pressurized metered dose inhaler (pMDI) or dry powder inhaler (DPI) devices.Objective: This study aimed to evaluate the frequency of exacerbations and satisfaction rate with device use in asthmatics using pMDIs or DPIs.Methods: A multicenter, cross-sectional study was conducted in adults who used pMDIs or DPIs with correct inhaler technique and good adherence for asthma treatment. Demographic and asthma-related characteristics of the subjects and data regarding device satisfaction were collected through a face-to-face interview in the outpatient clinic. Rates of pMDI and DPI users and the data were compared between the two groups.Results: The study included 338 patients (mean age: 48.6 +/- 14.5 years, 253 [74.9%] women). Among participants, 96 (28.4%) were using pMDI and 242 (71.6%) were using DPI. The age of patients using pMDI were significantly lower compared with DPI users. No significant difference was observed in terms of device satisfaction and clinical outcomes of asthma between pMDI and DPI users with good inhaler technique and good adherence.Conclusion: More asthmatics use DPIs, however, pMDIs are used in younger asthmatic patients. No significant difference in terms of device satisfaction and clinical outcomes of asthma was observed between pMDI and DPI users.
dc.description.sponsorshipThe study was presented at the Turkish Respiratory Society Congress held in Antalya in 2023.
dc.identifier.doi10.1089/jamp.2024.0006
dc.identifier.issn1941-2711
dc.identifier.issn1941-2703
dc.identifier.pmid39075039
dc.identifier.scopus2-s2.0-85200237117
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1089/jamp.2024.0006
dc.identifier.urihttps://hdl.handle.net/20.500.11776/14423
dc.identifier.wosWOS:001279094100001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMary Ann Liebert, Inc
dc.relation.ispartofJournal of Aerosol Medicine and Pulmonary Drug Delivery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAsthma
dc.subjectasthma exacerbation
dc.subjectasthma hospitalization
dc.subjectasthma treatment
dc.subjectdry powder inhaler
dc.subjectinhaler device
dc.subjectinhaler device satisfaction
dc.subjectinhaler treatment
dc.subjectpressurized metered dose inhaler
dc.subjectyoung asthmatics
dc.titleDemographic and Asthma-Related Characteristics of Asthmatics Using Pressurized Metered Dose Inhalers and Dry Powder Inhalers
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu